Keros Therapeutics, Inc. (KROS) total assets

Total assets · fiscal 2025
$338.02M

Keros Therapeutics, Inc. (KROS) had total assets of $338.02M at the end of fiscal 2025 (December 31, 2025). That is 45.1% lower than the $615.89M of fiscal 2024. Figures as of 18 Nov 2026, 12:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$338.02M
Change on fiscal 2024
−45.1%
Growth, 5 years
+4.6% a year
Highest on record
$615.89Mfiscal 2024
Lowest on record
$10.96Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Keros Therapeutics, Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 4.6% a year. Across the 7 fiscal years on record (2019–2025), the highest was $615.89M in fiscal 2024 and the lowest $10.96M in fiscal 2019.

History · 7 fiscal years

Total assets by fiscal year

Keros Therapeutics, Inc. total assets, year by year

Keros Therapeutics, Inc. (KROS) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$338.02M 45.1% down
2024$615.89M 66.4% up
2023$370.03M 20.6% up
2022$306.78M 20.2% up
2021$255.25M 5.3% down
2020$269.44M 2,359.5% up
2019$10.96M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on KROS

Keros Therapeutics, Inc., figure by figure

Keros Therapeutics, Inc. (KROS) overview: price, valuation and scorecard

Keros Therapeutics, Inc. total assets: questions and answers

How large are Keros Therapeutics, Inc.'s total assets?

Keros Therapeutics, Inc. (KROS) had total assets of $338.02M at the end of fiscal 2025 (December 31, 2025). That is 45.1% lower than the $615.89M of fiscal 2024.

What is the growth rate of Keros Therapeutics, Inc.'s total assets?

Over the five fiscal years to 2025 total assets grew at a compound 4.6% a year.

What are the highest and lowest total assets figures on record for Keros Therapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $615.89M in fiscal 2024 and the lowest $10.96M in fiscal 2019.

How is Keros Therapeutics, Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Keros Therapeutics, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Keros Therapeutics, Inc. (KROS) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/KROS/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.